JULIE K. HEIMBACH, M.D.

Plain English
This study looked at whether how long patients waited for a liver transplant after being registered impacted their chances of surviving with perihilar cholangiocarcinoma, a type of cancer. The researchers found that waiting for up to 6 months did not change overall survival rates for patients, as those who waited longer had similar outcomes to those who waited a shorter time. However, patients who waited at least 6 months before transplant had better survival outcomes after the surgery itself. Who this helps: This helps patients with perihilar cholangiocarcinoma and their doctors in understanding timing for liver transplants.

Plain English
This research paper updates guidelines for managing portopulmonary hypertension (POPH), a type of high blood pressure in the lungs that can occur with liver disease. Recent insights show that PORTOPULMONARY HYPERTENSION may improve after liver transplants, making them a viable option for some patients, even though previously, the risks were considered too high. The updated guidelines include new recommendations to help doctors provide better care for patients with POPH, based on the latest evidence and expert opinions. Who this helps: This helps patients with liver disease and high blood pressure in the lungs who are considering a liver transplant.

Plain English
This study examined a new deep learning model that analyzes MRI scans to detect early-stage perihilar cholangiocarcinoma (pCCA) in patients with primary sclerosing cholangitis (PSC). The model proved to be significantly better than expert radiologists, correctly identifying 87.9% of cases compared to 50.0% for the radiologists, and it maintained strong accuracy even in the absence of visible tumors. This is important because early detection of pCCA can lead to timely treatment, improving patient outcomes and survival rates. Who this helps: This benefits patients with primary sclerosing cholangitis and their doctors by improving early cancer detection.

Plain English
Researchers held a meeting to create guidelines for managing obesity in patients undergoing liver transplantation. They came up with 26 helpful recommendations that received very high agreement ratings from experts (98% for agreement and 97% for importance). These guidelines highlight the importance of good nutrition and physical activity and suggest using new treatments and considering weight-loss surgery for patients needing a liver transplant. Who this helps: This helps patients awaiting liver transplants and their doctors.

Plain English
This study looked at how liver transplant centers around the world operate, specifically examining their practices, financial support, and staffing. Researchers found that many centers are struggling, with over half stating they felt underpaid and nearly 70% indicating their funding was insufficient to meet their goals. Additionally, 60% reported challenges with finances, and a significant number felt they lacked the resources needed to provide high-quality care. This is important because identifying and improving these issues can lead to better outcomes for liver transplant patients. Who this helps: This helps liver transplant patients and the healthcare teams caring for them.

Plain English
The study looked at the challenges and risks associated with obesity in people who want to donate a kidney. It found that while obesity can lead to some health problems after donation, the overall risks are generally low and vary depending on a person’s health and fat distribution. The authors suggest that instead of strict weight limits, donors should be evaluated on a more personalized basis, considering their individual health circumstances, which could lead to fairer access to donation opportunities. Who this helps: This helps potential kidney donors, especially those who are obese, by improving their chances of being accepted as donors.

Plain English
This study developed a new scoring tool to predict which patients undergoing living donor liver transplantation are at the highest risk of losing their graft within 90 days. Using data from nearly 4,000 patients across 18 centers, the EAGLE-LDLT model—based on liver enzyme and clotting values in the first week after surgery—outperformed existing models and correctly identified 40% of high-risk patients. Surgeons can use this tool after transplant to flag patients who need closer monitoring or earlier intervention.

Plain English
This study looked at the long-term complications and outcomes for patients who had liver transplants due to primary sclerosing cholangitis (PSC) over 15 years. Out of 293 patients, complications such as biliary leaks and strictures occurred, with the risk of PSC returning increasing over time—34.3% of patients experienced recurrent PSC by 15 years after the transplant. Understanding these risks helps doctors manage and improve care for patients undergoing liver transplants. Who this helps: This helps liver transplant patients and their doctors by providing insights into potential long-term complications.

Plain English
This study looked at how the time taken between the moment a liver is clamped during surgery (cross-clamp) and when it is placed on a special machine (normothermic machine perfusion, or NMP) affects the function of the liver after transplantation in patients who received livers from donors who had died. The researchers found that when this waiting time was over 2 hours and 45 minutes, the risk of early liver dysfunction was higher, affecting 51.2% of these cases compared to 37.6% in those with shorter waiting times. This difference is important because it helps guide surgeons on how quickly they should act to prepare livers for transplant, improving outcomes for patients. Who this helps: This helps patients receiving liver transplants.

Plain English
The study looked at whether echocardiograms (a type of heart ultrasound) could effectively replace regular invasive heart tests (right heart catheterizations) for tracking severe portopulmonary hypertension (POPH) in patients waiting for liver transplants. Researchers found that echocardiograms showing a specific pressure reading (RVSP ≥48 mmHg) accurately identified all cases of severe POPH, meaning they could be a reliable alternative to the more invasive procedure. This is important because it could reduce the need for patients to undergo invasive testing every three months while still ensuring their safety and eligibility for a transplant. Who this helps: Patients with portopulmonary hypertension waiting for liver transplants.

Plain English
This study looked at how to better manage patients who need multiple organ transplants and have a high level of sensitization, meaning their bodies are more likely to reject new organs. Researchers found that practices for selecting and managing these patients vary greatly between the U.S. and the U.K., which can complicate their care. They also discussed the potential benefits of using liver transplants to help these patients get other organs, aiming to create a more standardized and evidence-based approach to their treatment. Who this helps: This helps patients needing multiple organ transplants and their doctors.

Plain English
This research studied the effects of doing a liver transplant alongside a procedure called sleeve gastrectomy for patients who are obese and have liver disease related to fat buildup. The study followed 72 patients who received both procedures, finding that after about 8 years, diabetes rates dropped significantly from 32% to 10% and hypertension fell from 61.1% to 35.8%. Patients lost a lot of weight, averaging 45.5 BMI at the start to a more healthy range, while those who only had a liver transplant did not experience notable weight loss. Who this helps: This helps patients with obesity and liver disease looking for more effective treatment options.

Plain English
This study looks at how to best manage liver transplant candidates who have both cirrhosis and obesity, as obesity is becoming more common among people needing liver transplants. Researchers found that medical and surgical treatments, especially if timed correctly, can improve outcomes for these patients. This matters because better management strategies can help patients live longer and healthier lives after a transplant. Who this helps: Patients with cirrhosis and obesity who are considering or awaiting a liver transplant.

Plain English
Researchers studied how well a new AI tool called the AI-Cirrhosis-ECG (ACE) score could predict severe liver problems and outcomes for patients with cirrhosis by analyzing thousands of heart scans. They found that the ACE score was very effective at identifying serious issues, having an accuracy score of 0.933, which means it was able to correctly identify problems 88% of the time while also reducing false alarms by 84%. This tool could significantly improve how doctors assess risks for patients with liver disease, helping them make better treatment decisions. Who this helps: This benefits patients with cirrhosis and their doctors by providing a more reliable way to predict serious health risks.

Plain English
This study looked at how obesity and liver disease, particularly a condition called MASLD, affect people who are candidates for or have received a liver transplant. It found that about 40% of adults in the U.S. have MASLD, and both obesity and this liver disease are becoming more common in transplant patients. The researchers explored the best ways to manage these issues, discussing whether medicine or surgery is the better treatment approach after a conference of experts. Who this helps: This benefits patients facing liver transplantation and healthcare providers who treat them.

Plain English
Researchers came together to create a set of recommendations for managing perihilar cholangiocarcinoma (pCCA), a rare type of liver cancer. They reviewed 570 studies and developed 71 recommendations on topics like diagnosis, treatment, and patient care, emphasizing that ensuring patients can receive high-quality surgeries is the top priority. This collective effort aims to improve treatment standards globally, which can lead to better outcomes for patients. Who this helps: This benefits patients with perihilar cholangiocarcinoma and their healthcare providers.

Plain English
This study developed a tool called the PRETREAT score to predict the chances of cancer returning in patients who have undergone liver transplantation for perihilar cholangiocarcinoma (pCCA). Researchers analyzed data from 399 patients and found that after five years, about 29.7% of those in the initial group and 27.6% of those in the follow-up group had their cancer come back. The tool helps doctors categorize patients into low, moderate, and high-risk groups—showing that the survival rates without recurrence after five years varied greatly: 89% for low-risk, 38% for moderate-risk, and only 15% for high-risk patients. Who this helps: This benefits patients with pCCA and their healthcare providers by improving post-transplant monitoring and treatment plans.

Plain English
This study looked at different treatment options for patients with a type of cancer called de novo perihilar cholangiocarcinoma. It found that liver transplantation after chemotherapy was better for survival than liver surgery without vascular removal, with patients living a median of 78 months compared to 58 months. However, when considering the number of patients who dropped out of treatment, the differences in survival weren't significant. Who this helps: This research helps doctors determine the best treatment options for patients with this specific type of cancer.

Plain English
This study examined how liver transplants from donors with fatty liver (steatotic grafts) affect outcomes in children. Out of 595 pediatric liver transplant recipients, 62 received grafts with more than 30% fat, and their survival rates were similar to those with less than 30% fat, with 10-year survival rates of 84.4% and 85.2%, respectively. The findings show that while steatotic grafts can work well, specific factors like donor age and whether the donation was after cardiac death significantly influence patient survival. Who this helps: This research benefits both pediatric patients receiving liver transplants and the doctors managing their care.

Plain English
This study looked at how different regions around the world allocate livers for transplantation, particularly focusing on special cases known as MELD exceptions for patients with certain liver cancers. It found that there are significant differences in how countries manage these exceptions and that understanding these variations can help improve liver transplant policies and outcomes. This matters because better allocation systems can lead to more successful transplants and save more lives. Who this helps: Patients in need of liver transplants and healthcare providers involved in liver transplantation.

Plain English
This study examined the outcomes and costs of kidney paired donation (KPD) compared to other kidney transplant methods for patients who can't receive a kidney from a living donor due to blood or tissue incompatibility. It found that the failure rates of transplanted kidneys in the external KPD group were slightly higher (3.3%) than in traditional deceased donor (2.7%), local KPD (1.0%), and living donor transplants (2.5%). Additionally, at 30 days post-transplant, the costs varied, with living donor transplants being the most expensive at around $115,597, while deceased donor transplants were the least costly at about $86,769. Who this helps: This research benefits patients needing kidney transplants, especially those with incompatible living donors.

Plain English
This study created a pretransplant prediction model to estimate the risk of early graft dysfunction after living donor liver transplantation, using only information available before surgery. Three factors predicted poor graft function: higher disease severity score, being hospitalized at the time of transplant, and receiving a smaller graft. The model can help surgeons better match donors to recipients before the operation to reduce complications.

Plain English
This study looked at the safety of weight loss surgery (bariatric surgery) for overweight patients who also have advanced chronic liver disease and high blood pressure in their blood vessels. Researchers reviewed the outcomes of 63 patients who had the surgery and found that only one patient (1.6%) died within 90 days of the surgery, and some experienced complications like blood clots and kidney issues, but overall the surgery was deemed safe. This matters because it shows that bariatric surgery can be a viable option for people with significant obesity and serious liver problems who need help losing weight. Who this helps: Overweight patients with chronic liver disease.

Plain English
This study looked at the treatment and long-term outcomes for 80 patients with a rare liver cancer called hepatic epithelioid hemangioendothelioma (HEHE) at Mayo Clinic. The researchers found that patients who had liver transplants had a three-year survival rate of 86.7%, compared to 80.9% for those who had parts of their liver removed, and only 51.1% for those who were managed with medical treatment alone. Importantly, patients with bone metastasis had a much higher risk of dying long-term, suggesting that surgery may not help those with bone spread, while it might still benefit patients with other types of metastases. Who this helps: This information helps doctors better decide on treatment options for patients with HEHE.

Plain English
This large international study of 3,633 living donor liver transplant patients identified risk factors for the two most common surgical complications: bile leaks and narrowing of the bile duct connection. Multiple bile duct connections, a history of prior abdominal surgery, and blood type incompatibility were among the key risk factors, and both complications significantly shortened graft survival. Careful donor selection and surgical planning are critical to reducing these complications.

Plain English
This study investigated how obesity affects the ability of stem cells from fat tissue to repair heart damage caused by high blood pressure. Researchers found that stem cells from obese individuals were less effective than those from lean individuals. Specifically, while both types of stem cells helped reduce heart damage, the lean cells worked better to improve heart function and decrease inflammation. Who this helps: This benefits patients with obesity-related heart issues.

Plain English
This study looked at how physical frailty, particularly a condition called sarcopenia (loss of muscle mass), affects patients waiting for liver transplants. The researchers found that frailty and sarcopenia are common among these patients, significantly increasing the risk of issues like hospital stays and infections, and impacting overall care costs. It’s important to address these conditions before and after transplantation to improve outcomes, and there’s a need for better understanding of how to treat them effectively. Who this helps: This helps liver transplant patients and their doctors.

Plain English
This study looked at how women face more challenges than men in receiving organ transplants in the U.S. It found that women are often at a disadvantage due to factors like barriers in getting referred for transplants, issues with matching donor and recipient sizes, and higher rates of sensitization to donor organs. To improve this situation, the researchers suggested changes to how organs are allocated, how donor organs are prepared, and how patients' health is assessed before a transplant. Who this helps: This helps women who need organ transplants.

Plain English
An international team of 15 high-volume liver transplant centers established reference benchmarks for living donor liver transplantation outcomes, similar to quality standards that exist for other surgical procedures. Living donor transplants matched or outperformed deceased donor transplants on most measures like graft loss and need for retransplantation, though bile leaks and hepatic artery clots remained higher. These benchmarks give transplant programs a concrete target for quality improvement and international comparison.

Plain English
This study looked at the role of a protein called PSMA in liver cancer, specifically hepatocellular carcinoma (HCC). Researchers found that 91% of liver cancer samples expressed PSMA, and those with higher grades of cancer had more PSMA. The study also showed that liver cancer lesions had a significant uptake of a PET scanning agent, indicating PSMA could be a useful target for diagnosing and treating HCC. Who this helps: This research benefits patients with hepatocellular carcinoma and doctors treating them.

Plain English
This study looked at how patients with hepatopulmonary syndrome (HPS) do in the hospital and intensive care unit (ICU) after undergoing a liver transplant. Researchers examined data from 137 patients and found that 95.6% needed mechanical ventilation, but most (74%) were able to breathe on their own within 24 hours. The overall risk of dying in the hospital was low at 3.6%, and how severe the HPS was did not affect survival rates. Who this helps: This research benefits doctors and healthcare providers managing liver transplant patients with HPS.

Plain English
This study looked at how improving the nutritional health of patients before liver transplantation could affect their recovery after the surgery. The researchers reviewed data from several studies and found that there was no significant difference in survival rates or complications after the transplant, but some studies suggested that improving vitamin D levels might help patients stay in the hospital for a shorter time. This is important because better nutrition before surgery may lead to a smoother recovery for some patients. Who this helps: This helps patients waiting for liver transplants and their healthcare teams.

Plain English
This study looked at how DNA changes in liver tissue from patients with severe liver diseases, specifically primary sclerosing cholangitis and primary biliary cholangitis, compared to other liver conditions and healthy donors. Researchers analyzed the DNA of 58 patients and found that those with cholestatic liver diseases had overall lower levels of DNA methylation, which affected specific genes and biological pathways. This is important because understanding these changes could help explain how these liver diseases develop and progress. Who this helps: Patients with cholestatic liver diseases and their doctors.

Plain English
This study looked at complications that can occur after a specific type of kidney removal surgery from living donors called hand-assisted laparoscopic living donor nephrectomy (HALLDN). Out of over 3,000 surgeries analyzed, 12.4% of patients had complications, with 76% of those complications happening after they left the hospital; specifically, 2.5% faced major complications, and 1.8% needed reoperation. This is important because it highlights the need for careful follow-up after discharge, as many issues arise later than expected. Who this helps: This research benefits patients who are living kidney donors by improving post-surgery care and monitoring.

Plain English
This study looked at patients with portopulmonary hypertension (POPH) who were granted special exceptions to the standard criteria for liver transplants between 2006 and 2019. Researchers found that 504 patients received these exceptions, and over the years, patients tended to be older and had more severe liver disease. Treatments for POPH have improved, leading to better blood pressure measurements in the lungs, but there was no significant change in waiting times or survival rates for transplants during this period. Who this helps: This information benefits patients with POPH and liver disease, as well as doctors managing their care.

Plain English
This study looked at the recurrence of primary sclerosing cholangitis (PSC) in 531 liver transplant patients. About 25% of them experienced a return of PSC within roughly 6.7 years after their transplant. The researchers found that higher levels of inflammation, both before and after the transplant, increased the risk of this recurrence, and that having recurrent cholangitis before the transplant raised the risk significantly (3.6 times more likely). Interestingly, having a colectomy (removal of the colon) before the transplant did not help reduce this risk. Who this helps: This information is valuable for patients with PSC and their doctors in managing and preventing complications after liver transplantation.

Plain English
This study looked at the long-term outcomes for people who donated a part of their liver and found that they generally stay healthy, with survival rates similar to that of non-donors. However, two related studies presented their findings differently, with one creating unnecessary fear through misleading comparisons. It’s important for medical data to be shared honestly so that both potential donors and medical professionals can make informed decisions about living liver donation. Who this helps: This helps patients considering live liver donation and their doctors.

Plain English
This study looked at patients in the U.S. with early stage intrahepatic cholangiocarcinoma (iCCA), a type of liver cancer, from 2004 to 2018. It found that while the number of early stage cases increased, only 42.5% of patients received surgery to possibly cure their cancer. The research also revealed that Hispanic and Black patients were less likely to get these curative treatments compared to White patients, which may affect their chances of survival. Who this helps: This helps patients and healthcare providers address treatment disparities in liver cancer care.

Plain English
This 17-center international benchmark study defined outcomes for liver transplantation in patients with early-stage bile duct cancer treated with neoadjuvant chemoradiation. Five-year disease-free survival was 62% after transplant versus 32% after liver resection in matched patients. Transplantation for this indication should be considered a standard option and may actually be superior to surgery in early-stage disease.